Odonate Therapeutics Statistics
Total Valuation
ODTC has a market cap or net worth of $67.36 million. The enterprise value is -$22.82 million.
| Market Cap | 67.36M |
| Enterprise Value | -22.82M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ODTC has 19,245 shares outstanding.
| Shares Outstanding | 19,245 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.37% |
| Float | 17,568 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.29 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -123.82 |
Financial Efficiency
Return on equity (ROE) is -157.61% and return on invested capital (ROIC) is -108.16%.
| Return on Equity (ROE) | -157.61% |
| Return on Assets (ROA) | -106.35% |
| Return on Capital (ROIC) | -108.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$821,095 |
| Employee Count | 137 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ODTC has paid $10.42 million in taxes.
| Income Tax | 10.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +194,344.44% in the last 52 weeks. The beta is -0.21, so ODTC's price volatility has been lower than the market average.
| Beta (1Y) | -0.21 |
| 52-Week Price Change | +194,344.44% |
| 50-Day Moving Average | 2,034.44 |
| 200-Day Moving Average | 509.93 |
| Relative Strength Index (RSI) | 66.37 |
| Average Volume (30 Days) | 1 |
Short Selling Information
The latest short interest is 189, so 0.98% of the outstanding shares have been sold short.
| Short Interest | 189 |
| Short Previous Month | 256 |
| Short % of Shares Out | 0.98% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 0.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -82.44M |
| Pretax Income | -102.07M |
| Net Income | -112.49M |
| EBITDA | -80.98M |
| EBIT | -81.48M |
| Earnings Per Share (EPS) | -$5,986.61 |
Balance Sheet
The company has $95.03 million in cash and $4.85 million in debt, giving a net cash position of $90.18 million or $4,685.84 per share.
| Cash & Cash Equivalents | 95.03M |
| Total Debt | 4.85M |
| Net Cash | 90.18M |
| Net Cash Per Share | $4,685.84 |
| Equity / Book Value | 71.37M |
| Book Value Per Share | 3,708.55 |
| Working Capital | 69.29M |
Cash Flow
In the last 12 months, operating cash flow was -$94.54 million and capital expenditures -$42,000, giving a free cash flow of -$94.58 million.
| Operating Cash Flow | -94.54M |
| Capital Expenditures | -42,000 |
| Free Cash Flow | -94.58M |
| FCF Per Share | -$4,988.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ODTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.55% |
| Shareholder Yield | -15.55% |
| Earnings Yield | -167.00% |
| FCF Yield | -140.41% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 9, 2024. It was a reverse split with a ratio of 1:5.
| Last Split Date | Apr 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |